R&D Systems™ Recombinant Human Latent BMP-9 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 9624BP025/CF

Catalog No. 9624BP025CF

Description

The Recombinant Human Latent BMP-9 Protein is derived from CHO. The Recombinant Human Latent BMP-9 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9UK05
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 2658
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: BMP9, BMP9BMP-9Bone morphogenetic protein 9, GDF2, GDF-2, growth differentiation factor 2, growth/differentiation factor 2
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 250μg/mL in PBS.

• Characterization: Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight (g/mol): 33kDa (pro) and 12kDa (mature)
• Source: Chinese Hamster Ovary cell line,CHO-derived human BMP-9 protein Lys23-Arg319 (pro) & Ser320-Arg429 (mature)
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Product Type: Recombinant Protein
• Species: Human
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.